Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 134

Tests names and labsConditionsGenes, analytes, and microbesMethods

Parkinsons disease panel

Centogene AG - the Rare Disease Company
Germany
2830
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7851205
  • C Sequence analysis of the entire coding region

DYT12 dystonia parkinsonism

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Neurodevelopmental Disorders Panel

Invitae
United States
404241
  • D Deletion/duplication analysis

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics
United States
340153
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Familial Hemiplegic Migraine Panel

Invitae
United States
217
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Comprehensive Deafness Panel

Invitae
United States
4421
  • D Deletion/duplication analysis

Episodic Ataxia Panel

PreventionGenetics
United States
6136
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Cerebral Palsy Spectrum Disorders Panel

Invitae
United States
413265
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy Panel

Molecular Genetics Laboratory London Health Sciences Centre
Canada
1166
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Epilepsy and Seizure Panel

PreventionGenetics
United States
485374
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CAPOS syndrome, 601338, Autosomal dominant; CAPOS (Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome) (Prenatal) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

CAPOS syndrome, 601338, Autosomal dominant; CAPOS (Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome) (ATP1A3 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

CAPOS syndrome, 601338, Autosomal dominant; CAPOS (Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

CAPOS syndrome, 601338, Autosomal dominant; CAPOS (Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome) (ATP1A3 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Dystonia-12, 128235, Autosomal dominant; DYT12 (Rapid-onset dystonia-parkinsonism) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Dystonia-12, 128235, Autosomal dominant; DYT12 (Rapid-onset dystonia-parkinsonism) (ATP1A3 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Alternating hemiplegia of childhood 2, 614820, Autosomal dominant; AHC2 (Alternating hemiplegia of childhood) (ATP1A3 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Alternating hemiplegia of childhood 2, 614820, Autosomal dominant; AHC2 (Alternating hemiplegia of childhood) (Prenatal) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Alternating hemiplegia of childhood 2, 614820, Autosomal dominant; AHC2 (Alternating hemiplegia of childhood) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Results: 1 to 20 of 134

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center